The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory processes.

The Food and Drug Administration is taking a new approach to COVID-19 vaccines that would prioritize ... But critics say the new requirements bypass the usual input from independent outside ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.